Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Schouten PC"'
Autor:
Abraham JE; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK. ja344@cam.ac.uk.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK. ja344@cam.ac.uk., Pinilla K; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK., Dayimu A; Cambridge Cancer Trials Centre, University of Cambridge, Cambridge, UK., Grybowicz L; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Demiris N; Department of Statistics, Athens University of Economics and Business, Athens, Greece., Harvey C; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Drewett LM; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Lucey R; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK., Fulton A; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK., Roberts AN; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Worley JR; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK., Chhabra A; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Qian W; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Vallier AL; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Hardy RM; Cambridge Cancer Trials Centre, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Chan S; The City Hospital, Nottingham University Hospitals NHS Trust, Nottingham, UK., Hickish T; Royal Bournemouth General Hospital, Bournemouth, UK., Tripathi D; Royal Wolverhampton NHS Trust, Wolverhampton, UK.; Russells Hall Hospital, Dudley, UK., Venkitaraman R; Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, Ipswich, UK., Persic M; University Hospital of Derby and Burton, Derby, UK., Aslam S; Bedford Hospital, Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK., Glassman D; Pinderfields Hospital, Mid Yorkshire Teaching NHS Trust, Wakefield, UK., Raj S; University Hospital Southampton NHS Foundation Trust, Southampton, UK.; Basingstoke & North Hampshire Hospital, Basingstoke, UK.; Royal Hampshire Hospital, Winchester, UK., Borley A; Velindre Cancer Centre, Cardiff, UK., Braybrooke JP; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Sutherland S; Mount Vernon Cancer Centre, Northwood, UK., Staples E; Queens Hospital, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Scott LC; Beatson West Of Scotland Cancer Centre, Glasgow, UK., Davies M; Swansea Bay University Health Board, Swansea, UK., Palmer CA; Hinchingbrooke Hospital, North West Anglia NHS Foundation Trust, Huntingdon, UK., Moody M; Macmillan Unit, West Suffolk Hospital NHS Foundation Trust, Bury Saint Edmunds, UK., Churn MJ; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.; Alexandra Redditch Hospital, Redditch, UK.; Kidderminster Hospital, Kidderminster, Worcestershire, UK., Newby JC; Royal Free London NHS Foundation Trust, London, UK., Mukesh MB; Oncology Department, Colchester General Hospital, East Suffolk & North Essex NHS Trust, Colchester, UK., Chakrabarti A; University Hospitals Dorset NHS Foundation Trust, Poole, UK., Roylance RR; University College London Hospitals NHS Foundation Trust, London, UK., Schouten PC; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Levitt NC; Oxford University Hospital NHS Foundation Trust, Oxford, UK., McAdam K; Peterborough City Hospital, North West Anglia NHS Foundation Trust, Peterborough, UK., Armstrong AC; The Christie NHS Foundation Trust and Division of Cancer Sciences, Manchester, UK., Copson ER; Cancer Sciences Academic Unit, University of Southampton, Southampton, UK., McMurtry E; EMC2 Clinical Consultancy, Sale, Manchester, UK., Tischkowitz M; Department of Medical Genetics, National Institute for Health Research, Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK., Provenzano E; Department of Histopathology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Earl HM; Precision Breast Cancer Institute, Department of Oncology, University of Cambridge, Cambridge, UK.; Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK.
Publikováno v:
Nature [Nature] 2024 May; Vol. 629 (8014), pp. 1142-1148. Date of Electronic Publication: 2024 Apr 08.
Autor:
Schouten PC; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schmidt S; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Medical Faculty, University Hospital Cologne, Cologne, Germany., Becker K; Cologne Center for Genomics, University of Cologne, Cologne, Germany., Thiele H; Cologne Center for Genomics, University of Cologne, Cologne, Germany., Nürnberg P; Cologne Center for Genomics, University of Cologne, Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne, University Hospital, Cologne, Cologne, Germany., Richters L; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Medical Faculty, University Hospital Cologne, Cologne, Germany., Ernst C; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Medical Faculty, University Hospital Cologne, Cologne, Germany., Treilleux I; Centre Léon BERARD, Lyon France., Medioni J; Hôpital Européen Georges Pompidou, Paris and Groupe d'Investigateurs Nationaux pour les Etudes des Cancers de l'Ovaire, France., Heitz F; Department of Gynecology & Gynecologic Oncology, EvangKliniken Essen-Mitte, Essen, Germany.; AGO Study Group, Wiesbaden, Germany., Pisano C; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G Pascale, Napoli, Italy., Garcia Y; Parc Taulí University Hospital, Sabadell, Spain and GEICO, Spain., Petru E; Department of Obstetrics and Gynecology, Medical University of Graz, Graz and AGO Austria, Austria., Hietanen S; Turku University Hospital, Turku, and Nordic Society of Gynaecological Oncology, Finland., Colombo N; University of Milan-Bicocca and European Institute of Oncology Scientific Institute for Research, Hospitalization and Healthcare, Milan, and MaNGO, Italy., Vergote I; University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union and BGOG, Belgium., Nagao S; Department of Gynecologic Oncology, Hyogo Cancer Center, Hyogo, Japan a,d GOTIC, Japan., Linn SC; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Pujade-Lauraine E; ARCAGY Research, Paris., Ray-Coquard I; Centre Léon BERARD, and University Claude Bernard Lyon I, Lyon and GINECO, France., Harter P; Department of Gynecology & Gynecologic Oncology, EvangKliniken Essen-Mitte, Essen, Germany.; AGO Study Group, Wiesbaden, Germany., Hahnen E; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Medical Faculty, University Hospital Cologne, Cologne, Germany., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology, Medical Faculty, University Hospital Cologne, Cologne, Germany.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Apr 01; Vol. 7 (4), pp. e245552. Date of Electronic Publication: 2024 Apr 01.
Autor:
Wang Y; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Dackus GMHE; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Rosenberg EH; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Cornelissen S; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Boo LW; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brugman W; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Chan TWS; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Isaeva OI; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Jong VMT; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Koop E; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, The Netherlands., Nederlof PM; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Schouten PC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., van Steenis C; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Vreuls W; Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Salgado RF; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Center, Melbourne, Australia., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. mk.schmidt@nki.nl.
Publikováno v:
BMC medicine [BMC Med] 2024 Jan 09; Vol. 22 (1), pp. 9. Date of Electronic Publication: 2024 Jan 09.
Autor:
Heitz F; AGO Studygroup and Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany florian.heitz@gmx.net.; Department for Gynecology with the Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Berlin Institute of Health, Berlin, Germany., Marth C; Department of Obstetrics and Gynecology, Innsbruck Medical University, Innsbruck, Austria., Henry S; CHU UCL Namur Site Sainte Elisabeth, Namur, Belgium., Reuss A; Coordinating Centre for Clinical Trials, Philipps-Universität Marburg, Marburg, Germany., Cibula D; CEEGOG & Department of Obstetrics and Gynecology, First Medical Faculty of the Charles University, Prague, Czech Republic., Gaba Garcia L; Department of Medical Oncology, Hospital Clinic Barcelona, Barcelona, Spain., Colombo N; Medical Gynecologic Oncology Unit, University of Milan Bicocca, Milan, Italy.; European Institute of Oncology, Milan, Italy., Schmalfeld B; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., de Gregorio N; Klinikum am Gesundbrunnen, SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany., Wimberger P; Gyncology and Obstetrics, Technische Universitat Dresden Medizinische Fakultat Carl Gustav Carus, Dresden, Germany., Hasenburg A; Obstetrics and Gynecology, Mainz University, Mainz, Germany., Sehouli J; Gynecology with Center of Oncological Surgery, Charite Universitatsmedizin Berlin, Berlin, Germany., Gropp-Meier M; Oberschwabenklinik gGmbH, Ravensburg, Baden-Württemberg, Germany., Schouten PC; University Hospital Cologne, Cologne, Germany., Hahnen E; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany., Hauke J; University Hospital Cologne, Cologne, Germany., Polleis S; AGO Study Group, Wiesbaden, Germany., Harter P; AGO Studygroup and Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2023 Dec 04; Vol. 33 (12), pp. 1966-1969. Date of Electronic Publication: 2023 Dec 04.
Autor:
van Wagensveld L; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.; Department of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; GROW, School for Oncology and Reproduction, 6229 HX Maastricht, The Netherlands., van Baal JOAM; Department of Gynecology, Center for Gynecologic Oncology Amsterdam (CGOA), 1066 CX Amsterdam, The Netherlands., Timmermans M; Department of Obstetrics and Gynecology, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands., Gaillard D; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Borghuis L; Department of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Coffelt SB; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Institute of Cancer Sciences, University of Glasgow, Glasgow G12 8QQ, UK.; Cancer Research UK, Beatson Institute, Glasgow G61 1BD, UK., Rosenberg EH; Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Lok CAR; Department of Gynecology, Center for Gynecologic Oncology Amsterdam (CGOA), 1066 CX Amsterdam, The Netherlands., Nijman HW; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands., Kooreman LFS; GROW, School for Oncology and Reproduction, 6229 HX Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., de Bruijn M; Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The Netherlands., Wessels LFA; Department of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., van der Wiel R; Department of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Rausch C; Department of Pathology, VU University Medical Center, 1081 HV Amsterdam, The Netherlands.; BioLizard nv, 9000 Ghent, Belgium., Broeks A; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Kruitwagen RFPM; GROW, School for Oncology and Reproduction, 6229 HX Maastricht, The Netherlands.; Department of Obstetrics and Gynecology, Maastricht University Medical Centre, 6229 HX Maastricht, The Netherlands., van der Aa MA; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Schouten PC; Department of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Van de Vijver KK; Department of Gynecology, Center for Gynecologic Oncology Amsterdam (CGOA), 1066 CX Amsterdam, The Netherlands.; Department of Pathology & Cancer Research Institute Ghent (CRIG), Ghent University Hospital, 9000 Ghent, Belgium., Horlings HM; Department of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Dec 02; Vol. 14 (23). Date of Electronic Publication: 2022 Dec 02.
Autor:
Koole SN; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Driel WJ; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2022 Dec 01; Vol. 151 (11), pp. 2057-2058. Date of Electronic Publication: 2022 Aug 05.
Autor:
Koole SN; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hauke J; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Nederlof P; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Richters LK; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Krebsbach G; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Sikorska K; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Alkemade M; Core Facility of Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Core Facility of Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schagen van Leeuwen JH; Department of Obstetrics & Gynecology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Schreuder HWR; Department of Gynecological Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Hermans RHM; Department of Gynecology and Obstetrics, Catharina Hospital, Eindhoven, The Netherlands., de Hingh IHJT; Department of Surgical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Mom CH; Department of Obstetrics and Gynecology, Amsterdam University Medical Center, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Arts HJG; Department of Gynecological Oncology, University Medical Center Groningen, Groningen, The Netherlands., van Ham M; Department of Gynecological Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van Dam P; Department of Gynecologic Oncology, University Hospital Antwerp, Antwerp, Belgium., Vuylsteke P; Department of Medical Oncology, UCL Louvain, CHU Namur Sainte-Elisabeth, Namur, Belgium.; University of Botswana, Gaborone, Botswana., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van de Vijver KK; Department of Pathology, University Hospital Ghent, Ghent, Belgium., Hahnen E; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., van Driel WJ; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Schmutzler R; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2022 Oct 15; Vol. 151 (8), pp. 1394-1404. Date of Electronic Publication: 2022 Jun 04.
Autor:
de Boo LW; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Lindman H; Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden., Lauttia S; Laboratory of Molecular Oncology, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Steenis C; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Brugman W; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kluin RJC; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nederlof PM; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl.; Department of Pathology, University Medical Centre, Utrecht, The Netherlands. s.linn@nki.nl.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Jun; Vol. 126 (10), pp. 1401-1409. Date of Electronic Publication: 2022 Feb 05.
Autor:
Schouten PC; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. p.schouten@nki.nl., Richters L; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany., Vis DJ; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., van Dijk E; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ernst C; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Marmé F; Department of Gynecologic Oncology, Medical Faculty Mannheim, University of Heidelberg, University Hospital Mannheim, Mannheim, Germany., Lips EH; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schmidt S; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany., Scheerman E; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Prieske K; Department of Gynecology and Gynecologic Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., van Deurzen CHM; Department of Pathology, Erasmus MC, Rotterdam, the Netherlands., Burges A; Department of Gynecology and Obstetrics, University Hospital Munich-Großhadern, Munich, Germany., Ewing-Graham PC; Department of Pathology, Erasmus MC, Rotterdam, the Netherlands., Dietrich D; Department of Otolaryngology, Head and Neck Surgery, University Hospital Bonn, Bonn, Germany., Jager A; Department of Medical Oncology, Erasmus MC, Rotterdam, the Netherlands., de Gregorio N; Department of Gynecology and Obstetrics, University Hospital, University of Ulm, Ulm, Germany., Hauke J; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany., du Bois A; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany., Nederlof PM; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LF; Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Faculty of Electrical Engineering, Mathematics and Computer Science, Delft University of Technology, Delft, the Netherlands., Hahnen E; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany., Harter P; Department of Gynecology and Gynecologic Oncology, Ev. Kliniken Essen-Mitte, Essen, Germany., Linn SC; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Dec 01; Vol. 27 (23), pp. 6559-6569. Date of Electronic Publication: 2021 Sep 30.
Autor:
Geenen JJJ; Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Dackus GMHE; Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Utrecht University Medical Center, Utrecht, The Netherlands., Schouten PC; Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands., Pluim D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Marchetti S; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands., Jóźwiak K; Brandenburg Medical School Theodor Fontane, Institute of Biostatistics and Registry Research, Neuruppin, Germany., Huitema ADR; Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, Utrecht University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands., Beijnen JH; Department of Clinical Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, Utrecht University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands., Schellens JHM; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht, The Netherlands., Linn SC; Department of Molecular Pathology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Utrecht University Medical Center, Utrecht, The Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2021 Jun 15; Vol. 148 (12), pp. 3041-3050. Date of Electronic Publication: 2021 Feb 27.